Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Abbott mPlus for RealTime m2000 System


Abbott this week introduced the mPlus, a new capability for its RealTime m2000 molecular diagnostics system.

The mPlus capability makes it possible for laboratories of any size to perform molecular diagnostic tests for infectious disease detection and therapy monitoring. Specifically, it will give laboratories the ability to process samples when they are ready rather than holding them for larger batch runs, thus providing faster results to patients. mPlus will also optimize reagent use, reduce laboratory cost of operations, and offer a new automatic inventory feature to improve system and ease of use, Abbott said.

mPlus capability is currently available for Abbott's RealTime HIV, HCV, HBV, CT/NG, and CT assays outside the US and for the RealTime CT/NG assay within the US.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.